| LD SNP | LD R2 | Risk Allele | Gene | Trait Class | Trait | OR/Beta | P-value | Study | Ancestry |
|---|
| 6-32435139-C-T | AFR:0.28 AMR:0.21 EAS:0.62 EUR:0.22 SAS:0.93 10K:0.57 | rs144123929-C | | Lipid or lipoprotein measurement | Cholesteryl esters to total lipids ratio in IDL | 0.0862226 | 1E-8 | GCST90092834 | European |
| 6-32523760-C-T | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.90 SAS:0.94 10K:0.70 | rs1613056-? | | Immune system disorder | Hypothyroidism or rheumatoid arthritis (pleiotropy) | | 3E-99 | GCST90428109 | European |
| 6-32528694-C-A | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs1617322-? | | Immune system disorder | Hypothyroidism or rheumatoid arthritis (pleiotropy) | | 3E-98 | GCST90428109 | European |
| 6-32523477-G-A | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.70 | rs1794277-? | | Other measurement | Seropositivity for streptococcus pneumoniae peptide (agilent_223208) | 10.148 | 3E-24 | GCST90295773 | NR |
| 6-32523477-G-A | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.70 | rs1794277-? | | Immune system disorder | Hypothyroidism or rheumatoid arthritis (pleiotropy) | | 3E-99 | GCST90428109 | European |
| 6-32522006-A-T | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs1794280-T | NR | Other measurement | Anti-sp100 seropositivity in primary biliary cholangitis | 3.89 | 6E-28 | GCST007737 | East Asian |
| 6-32522006-A-T | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs1794280-T | | Other disease | Hyperthyroidism | 0.5463 | 2E-44 | GCST90018860 | European, East Asian |
| 6-32522006-A-T | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs1794280-? | | Immune system disorder | Hypothyroidism or rheumatoid arthritis (pleiotropy) | | 1E-101 | GCST90428109 | European |
| 6-32521193-C-T | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.73 | rs1794283-? | | Immune system disorder | Hypothyroidism or rheumatoid arthritis (pleiotropy) | | 4E-101 | GCST90428109 | European |
| 6-32526012-T-G | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs1794511-G | | Other measurement | IgD on IgD+ CD24+ B cell | 0.2439 | 7E-13 | GCST90001820 | European |
| 6-32526012-T-G | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs1794511-T | | Other trait | Amiloride-sensitive amine oxidase [copper-containing] levels | 0.132 | 9E-12 | GCST90246408 | European |
| 6-32526012-T-G | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs1794511-? | | Immune system disorder | Hypothyroidism or rheumatoid arthritis (pleiotropy) | | 7E-99 | GCST90428109 | European |
| 6-32517298-A-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.90 SAS:0.94 10K:0.70 | rs1794519-? | | Immune system disorder | Hypothyroidism or rheumatoid arthritis (pleiotropy) | | 1E-100 | GCST90428109 | European |
| 6-32526605-T-G | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs1794530-? | | Immune system disorder | Hypothyroidism or rheumatoid arthritis (pleiotropy) | | 2E-99 | GCST90428109 | European |
| 6-32522723-G-A | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs2647044-A | BRD2, BTNL2, C6orf10, HCG23, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DQB2, HLA-DRA, HLA-DRB1, HLA-DRB5, HLA-DRB6, LOC100294145, NOTCH4, PSMB8, PSMB9, TAP1, TAP2, TAPSAR1 | Other disease | Asthma | 1.1522182 | 4E-15 | GCST008916 | European |
| 6-32522723-G-A | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs2647044-A | HLA-DRB1 | Immune system disorder | Type 1 diabetes | 8.3 | 1E-16 | GCST000054 | European |
| 6-32522723-G-A | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs2647044-G | HLA-DQB1 | Other measurement | Pulmonary function | 0.044 | 6E-6 | GCST001248 | European |
| 6-32522723-G-A | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs2647044-? | | Other measurement | Seropositivity for staphylococcus aureus peptide (agilent_226247) | 8.569 | 1E-17 | GCST90295547 | NR |
| 6-32522723-G-A | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs2647044-? | | Other measurement | Seropositivity for staphylococcus aureus peptide (agilent_222381) | 9.68 | 4E-22 | GCST90295549 | NR |
| 6-32522723-G-A | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs2647044-? | | Other measurement | Seropositivity for staphylococcus aureus peptide (agilent_236333) | 8.91 | 5E-19 | GCST90295552 | NR |
| 6-32522723-G-A | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs2647044-? | | Other measurement | Seropositivity for staphylococcaceae peptide (agilent_4825) | 9.322 | 1E-20 | GCST90295458 | NR |
| 6-32513786-A-G | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs2856674-A | BRD2 | Other measurement | Feeling nervous | 6.41 | 2E-10 | GCST006948 | European |
| 6-32513786-A-G | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs2856674-? | HLA-DQA | Digestive system disorder | Primary sclerosing cholangitis | | 1E-6 | GCST006670 | European |
| 6-32513786-A-G | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs2856674-G | MTCO3P1 | Body measurement | A body shape index | 0.0297899 | 7E-14 | GCST90020024 | European |
| 6-32513786-A-G | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs2856674-G | | Hematological measurement | Hemoglobin concentration | 0.05117 | 1E-22 | GCST90258652 | European |
| 6-32499706-T-C | AFR:0.84 AMR:0.46 EAS:0.60 EUR:0.92 SAS:0.94 10K:0.70 | rs3104361-T | HLA-DQB1 | Other measurement | Helicobacter pylori OMP antibody levels | 0.18 | 7E-10 | GCST90006914 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | HLA-DQB1 | Immune system disorder | Systemic lupus erythematosus | | 4E-9 | GCST003103 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | FAM3B/GUCA2A protein level ratio | 0.166109 | 9E-66 | GCST90314779 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | HAVCR2/PILRA protein level ratio | 0.0835696 | 3E-18 | GCST90315028 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | HAVCR2/TNFRSF1B protein level ratio | 0.204194 | 1E-102 | GCST90315030 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | ITGA5/VCAM1 protein level ratio | 0.110806 | 4E-30 | GCST90315206 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | FOLR2/HAVCR2 protein level ratio | 0.165053 | 3E-69 | GCST90314865 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | CD300C/HAVCR2 protein level ratio | 0.103823 | 2E-27 | GCST90313789 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | CDCP1/MSR1 protein level ratio | 0.140893 | 4E-50 | GCST90313938 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | QPCT/RNASET2 protein level ratio | 0.336381 | 9E-274 | GCST90315758 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | ROBO2/SCARF2 protein level ratio | 0.0777629 | 4E-19 | GCST90315784 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | PLAUR/TREM2 protein level ratio | 0.101906 | 2E-27 | GCST90315676 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | EFNA1/TNFRSF1A protein level ratio | 0.11086 | 8E-33 | GCST90314599 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | IGSF8/NECTIN2 protein level ratio | 0.115734 | 1E-33 | GCST90315140 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | PIK3IP1/TNFRSF1A protein level ratio | 0.128004 | 3E-40 | GCST90315653 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | ADA2/COMP protein level ratio | 0.181174 | 2E-80 | GCST90313166 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Other measurement | ADGRE2/SIGLEC1 protein level ratio | 0.0933404 | 3E-22 | GCST90313178 | European |
| 6-32511584-T-C | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72 | rs3129716-? | | Neurological disorder | Polymyositis | 2.65 | 2E-54 | GCST90270217 | European |
| 6-32501585-A-C | AFR:0.84 AMR:0.46 EAS:0.60 EUR:0.92 SAS:0.94 10K:0.70 | rs3134971-C | | Other trait | Coiled-coil domain-containing protein 134 level in Chronic kidney disease with hypertension and no diabetes (15300_66) | 0.93 | 1E-21 | GCST90234306 | African American or Afro-Caribbean |
| 6-32499069-G-T | AFR:0.84 AMR:0.46 EAS:0.62 EUR:0.92 SAS:0.94 10K:0.71 | rs3134977-? | | Other measurement | Seropositivity for staphylococcus aureus peptide (twist_46764) | 7.175 | 7E-13 | GCST90295470 | NR |
| 6-32498901-A-T | AFR:0.84 AMR:0.46 EAS:0.62 EUR:0.92 SAS:0.94 10K:0.71 | rs3134978-A | | Other measurement | GDNF family receptor alpha-1 levels | 0.17 | 8E-20 | GCST90247719 | European |
| 6-32536438-C-T | AFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65 | rs3957147-T | NR | Immune system disorder | Autoimmune traits | 1.34 | 9E-9 | GCST011008 | European |
| 6-32536438-C-T | AFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65 | rs3957147-? | | Other measurement | Seropositivity for streptococcus pneumoniae peptide (agilent_220951) | 5.855 | 5E-9 | GCST90295790 | NR |
| 6-32536438-C-T | AFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65 | rs3957147-? | | Other measurement | Seropositivity for streptococcus pneumoniae peptide (agilent_220944) | 6.256 | 4E-10 | GCST90295776 | NR |
| 6-32536438-C-T | AFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65 | rs3957147-? | | Other measurement | Seropositivity for streptococcus pneumoniae peptide (agilent_220184) | 6.418 | 1E-10 | GCST90295777 | NR |
| 6-32536438-C-T | AFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65 | rs3957147-? | | Other measurement | Seropositivity for streptococcus pneumoniae peptide (agilent_231039) | 5.622 | 2E-8 | GCST90295781 | NR |
| 6-32536438-C-T | AFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65 | rs3957147-? | | Other measurement | Seropositivity for hordeum vulgare (barley) peptide (twist_15602) | 5.666 | 1E-8 | GCST90293451 | NR |
| 6-32536438-C-T | AFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65 | rs3957147-T | XXbac-BPG254F23.7 | Body measurement | Hip circumference adjusted for BMI | 0.0232882 | 5E-9 | GCST012227 | European |
| 6-32439175-G-C | AFR:0.37 AMR:0.79 EAS:0.96 EUR:0.91 SAS:0.93 10K:0.81 | rs535777-? | NR | Neurological disorder | Help-seeking from a GP | 1.0362694 | 5E-6 | GCST010011 | European |
| 6-32439175-G-C | AFR:0.37 AMR:0.79 EAS:0.96 EUR:0.91 SAS:0.93 10K:0.81 | rs535777-G | NR | Neurological disorder | Help-seeking from a psychiatrist | 1.0752687 | 1E-9 | GCST010012 | European |
| 6-32439175-G-C | AFR:0.37 AMR:0.79 EAS:0.96 EUR:0.91 SAS:0.93 10K:0.81 | rs535777-? | | Other measurement | Depression | 0.011 | 9E-10 | GCST90239706 | European, NR |
| 6-32439175-G-C | AFR:0.37 AMR:0.79 EAS:0.96 EUR:0.91 SAS:0.93 10K:0.81 | rs535777-G | | Cancer | Cancer (pleiotropy)(bidirectional) | | 4E-12 | GCST90011823 | European |
| 6-32533620-C-T | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.90 SAS:0.94 10K:0.70 | rs9275576-T | HLA-DQA2 | Other measurement | Coffee consumption (cups per day) | 0.048 | 6E-9 | GCST010108 | European |
| 6-32533620-C-T | AFR:0.84 AMR:0.46 EAS:0.58 EUR:0.90 SAS:0.94 10K:0.70 | rs9275576-T | | Other measurement | Secreted frizzled-related protein 3 levels | 0.169 | 6E-18 | GCST90249516 | European |